₂Koji Yamanegi

Summary for 2004 [at-glance overview of Koji Yamanegi work for the selected year as suggested by data mining algorithms]

This is an Authoratory overview of author Koji Yamanegi. According to available data, in 2004 Koji Yamanegi published at least 2 articles. This work was completed in collaboration with several authors including Zheng, Zhi-Ming and Xiao, Wei. There is no information about the funding or the grants awarded to support this work.

Analysis of the article abstracts and the titles suggests that Koji Yamanegi professional interests are focused around "intron rna cap", "lytic dna replication" and "splicing cap-proximal human". These might also be referred to as "e6e7 pre-mrna", "dna replication" or "rna cap". Statistical analysis shows that Koji Yamanegi's writing is likely to contains terms "splicing", "rna", "e6e7", "intron", "e7" and "dna".

The majority of Koji Yamanegi articles are affiliated with HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD Maryland 20892, USA. Luckily, one email address is on file.

EN FR ES RU

Inaccurate information, needs improvement

make correction leave comment ask question

Images [images we found on the Internet for Koji Yamanegi]

Do you know Koji Yamanegi who matches the profile above? Click the photo and let us know!

Alternative names (0) [other authors with names similar to Koji Yamanegi]

none

Year 2004 Charts [Koji Yamanegi frequent coauthors and the most common unique vocabulary terms for the selected year]

Historical Performance Charts [graphical overview of Koji Yamanegi publication and funding history for the range of years]

Emails (1) [email addresses extracted from Koji Yamanegi affiliations]

hidden to prevent spam, click here to reveal

Koji Yamanegi Coauthors (5) [all coauthors with the number of joint publications]

2

1

1

1

1

Other [context-specific ads]

Affiliations (1) [condensed summary of the Koji Yamanegi affiliations, the leading number and the color conveys importance]

₂HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD Maryland 20892, USA.

Key Opinion Leader In [Koji Yamanegi is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors]

no keywords assigned

Keywords (23) [keywords assigned to Koji Yamanegi articles by PubMed, the leading number and the color conveys importance]

₂Humans | ₁Base Sequence | ₁Alternative Splicing | ₁Butyrates | ₁Oncogene Proteins, Viral | ₁RNA Caps | ₁Introns | ₁Cell Line, Tumor | ₁Gene Expression Regulation, Viral | ₁3' Flanking Region | ₁5' Flanking Region | ₁Virus Activation | ₁Promoter Regions, Genetic | ₁Cell Line | ₁Herpesvirus 8, Human | ₁DNA Replication | ₁Protein Biosynthesis | ₁Sequence Deletion | ₁Ganciclovir | ₁RNA Splice Sites | ₁RNA, Viral | ₁Repressor Proteins | ₁Virus Replication

Koji Yamanegi Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; Koji Yamanegi might be a good expert witness on these terms]

₁₀splicing | ₁₀rna | ₉e6e7 | ₉intron | ₆e7 | ₆dna | ₆replication | ₅pre-mrna | ₅e6 | ₅cap-proximal | ₅distance | ₄human | ₄cap | ₄expression | ₄lytic | ₃efficient | ₃papillomavirus | ₃k8 | ₃activation | ₃viral | ₃splice | ₃sequence | ₃promoter | ₂restrained | ₂hpv16 | ₂can | ₂better | ₂inefficient | ₂promotes | ₂small | ₂exon | ₂requirement
₅e6e7 pre-mrna | ₅dna replication | ₄rna cap | ₃splicing e6e7 | ₃human papillomavirus | ₃e7 expression | ₃intron rna | ₃lytic dna | ₂cap-proximal human | ₂can restrained | ₂intron promotes | ₂e6e7 intron | ₂papillomavirus e6e7 | ₂expression can | ₂distance intron | ₂splicing cap-proximal | ₂restrained distance | ₂efficient splicing | ₂rna splicing | ₂hpv16 e6e7 | ₂promotes e7 | ₂replication activation | ₂cap-proximal intron | ₂e7 translation | ₂activation kaposi | ₂sequence viral | ₂requirement 12-base-pair | ₂late promoter | ₂tatt-containing sequence | ₂12-base-pair tatt-containing | ₂herpesvirus k8 | ₂k8 late
₃intron rna cap | ₃lytic dna replication | ₂splicing cap-proximal human | ₂distance intron rna | ₂can restrained distance | ₂intron promotes e7 | ₂e6e7 intron promotes | ₂expression can restrained | ₂hpv16 e6e7 pre-mrna | ₂restrained distance intron | ₂papillomavirus e6e7 intron | ₂splicing e6e7 pre-mrna | ₂promotes e7 expression | ₂cap-proximal human papillomavirus | ₂human papillomavirus e6e7 | ₂e7 expression can | ₂sarcoma-associated herpesvirus k8 | ₂12-base-pair tatt-containing sequence | ₂requirement 12-base-pair tatt-containing | ₂herpesvirus k8 late | ₂dna replication activation | ₂activation kaposi sarcoma-associated | ₂kaposi sarcoma-associated herpesvirus | ₂sequence viral lytic | ₂k8 late promoter | ₂replication activation kaposi | ₂viral lytic dna | ₂tatt-containing sequence viral | ₁cancer-derived cells producing | ₁kshv lytic dna | ₁due large size | ₁vector exon hpv16

Reader's Comments (0) [comments posted by readers of Koji Yamanegi profile]